1092 related articles for article (PubMed ID: 26465922)
1. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease.
Beyer K; Domingo-Sàbat M; Humbert J; Carrato C; Ferrer I; Ariza A
Neurogenetics; 2008 Jul; 9(3):163-72. PubMed ID: 18335262
[TBL] [Abstract][Full Text] [Related]
3. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
4. Synphilin-1 isoforms in Parkinson's disease: regulation by phosphorylation and ubiquitylation.
Szargel R; Rott R; Engelender S
Cell Mol Life Sci; 2008 Jan; 65(1):80-8. PubMed ID: 17982729
[TBL] [Abstract][Full Text] [Related]
5. Synphilin-1A: an aggregation-prone isoform of synphilin-1 that causes neuronal death and is present in aggregates from alpha-synucleinopathy patients.
Eyal A; Szargel R; Avraham E; Liani E; Haskin J; Rott R; Engelender S
Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5917-22. PubMed ID: 16595633
[TBL] [Abstract][Full Text] [Related]
6. LRRK2 and parkin immunoreactivity in multiple system atrophy inclusions.
Huang Y; Song YJ; Murphy K; Holton JL; Lashley T; Revesz T; Gai WP; Halliday GM
Acta Neuropathol; 2008 Dec; 116(6):639-46. PubMed ID: 18936941
[TBL] [Abstract][Full Text] [Related]
7. Synphilin isoforms and the search for a cellular model of lewy body formation in Parkinson's disease.
Eyal A; Engelender S
Cell Cycle; 2006 Sep; 5(18):2082-6. PubMed ID: 16969096
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.
Liani E; Eyal A; Avraham E; Shemer R; Szargel R; Berg D; Bornemann A; Riess O; Ross CA; Rott R; Engelender S
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5500-5. PubMed ID: 15064394
[TBL] [Abstract][Full Text] [Related]
9. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.
Chung KK; Zhang Y; Lim KL; Tanaka Y; Huang H; Gao J; Ross CA; Dawson VL; Dawson TM
Nat Med; 2001 Oct; 7(10):1144-50. PubMed ID: 11590439
[TBL] [Abstract][Full Text] [Related]
10. Parkin and synphilin-1 isoform expression changes in Lewy body diseases.
Humbert J; Beyer K; Carrato C; Mate JL; Ferrer I; Ariza A
Neurobiol Dis; 2007 Jun; 26(3):681-7. PubMed ID: 17467279
[TBL] [Abstract][Full Text] [Related]
11. Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
Puska G; Lutz MI; Molnar K; Regelsberger G; Ricken G; Pirker W; Laszlo L; Kovacs GG
Neurobiol Dis; 2018 Jun; 114():140-152. PubMed ID: 29505813
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders.
Wakabayashi K; Engelender S; Tanaka Y; Yoshimoto M; Mori F; Tsuji S; Ross CA; Takahashi H
Acta Neuropathol; 2002 Mar; 103(3):209-14. PubMed ID: 11907799
[TBL] [Abstract][Full Text] [Related]
13. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
14. Pael-R is accumulated in Lewy bodies of Parkinson's disease.
Murakami T; Shoji M; Imai Y; Inoue H; Kawarabayashi T; Matsubara E; Harigaya Y; Sasaki A; Takahashi R; Abe K
Ann Neurol; 2004 Mar; 55(3):439-42. PubMed ID: 14991825
[TBL] [Abstract][Full Text] [Related]
15. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation.
Lim KL; Chew KC; Tan JM; Wang C; Chung KK; Zhang Y; Tanaka Y; Smith W; Engelender S; Ross CA; Dawson VL; Dawson TM
J Neurosci; 2005 Feb; 25(8):2002-9. PubMed ID: 15728840
[TBL] [Abstract][Full Text] [Related]
16. FBXO7 immunoreactivity in α-synuclein-containing inclusions in Parkinson disease and multiple system atrophy.
Zhao T; Severijnen LA; van der Weiden M; Zheng PP; Oostra BA; Hukema RK; Willemsen R; Kros JM; Bonifati V
J Neuropathol Exp Neurol; 2013 Jun; 72(6):482-8. PubMed ID: 23656991
[TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy.
Mori F; Piao YS; Hayashi S; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K
J Neuropathol Exp Neurol; 2003 Aug; 62(8):812-9. PubMed ID: 14503637
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy.
Shoji M; Harigaya Y; Sasaki A; Uéda K; Ishiguro K; Matsubara E; Watanabe M; Ikeda M; Kanai M; Tomidokoro Y; Shizuka M; Amari M; Kosaka K; Nakazato Y; Okamoto K; Hirai S
J Neurol Neurosurg Psychiatry; 2000 May; 68(5):605-8. PubMed ID: 10766891
[TBL] [Abstract][Full Text] [Related]
19. Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia.
Miller DW; Johnson JM; Solano SM; Hollingsworth ZR; Standaert DG; Young AB
J Neural Transm (Vienna); 2005 Dec; 112(12):1613-24. PubMed ID: 16284907
[TBL] [Abstract][Full Text] [Related]
20. Synphilin-1A inhibits seven in absentia homolog (SIAH) and modulates alpha-synuclein monoubiquitylation and inclusion formation.
Szargel R; Rott R; Eyal A; Haskin J; Shani V; Balan L; Wolosker H; Engelender S
J Biol Chem; 2009 Apr; 284(17):11706-16. PubMed ID: 19224863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
